Mara Chambers

2 clinical trials · Sponsor

Record	Firm	Date
Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release (NCT01205503)	Mara Chambers	2010-09-01
Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure (NCT00570921)	Mara Chambers	2008-04-01

Every clearance here is in the API, with alerts when new ones post.